Intervention Review

Phosphodiesterase III inhibitors for heart failure

  1. Emmanuel Amsallem1,
  2. Christelle Kasparian2,
  3. G Haddour3,
  4. Jean-Pierre Boissel4,
  5. Patrice Nony5,*

Editorial Group: Cochrane Heart Group

Published Online: 24 JAN 2005

Assessed as up-to-date: 1 NOV 2004

DOI: 10.1002/14651858.CD002230.pub2


How to Cite

Amsallem E, Kasparian C, Haddour G, Boissel JP, Nony P. Phosphodiesterase III inhibitors for heart failure. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD002230. DOI: 10.1002/14651858.CD002230.pub2.

Author Information

  1. 1

    CETAF, Quality - Evaluation - Etudes, Saint-Etienne Cedex 02, France

  2. 2

    APRET/EZUS, Clinical Pharmacology Unit (EA 3736), Lyon, France

  3. 3

    Hospices Civils de Lyon, Cardiovscular Hospital Louis Pradel, Lyon, France

  4. 4

    Hopital Cardio-Vasculaire et Pneumologique Louis Pradel, Centre d'Investigation Clinique - CIC de Lyon, Bron, CEDEX, France

  5. 5

    Hopital Neurocardiologique, Lyon, France

*Patrice Nony, Hopital Neurocardiologique, 28 avenue Doyen Lepine, Lyon, 69003, France. pn@upcl.univ-lyon1.fr.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 24 JAN 2005

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    John M. Nicklas, Barry E. Bleske, Richard Van Harrison, Robert V. Hogikyan, Yeong Kwok, William E. Chavey, Heart Failure, Primary Care: Clinics in Office Practice, 2013, 40, 1, 17

    CrossRef

  2. You have free access to this content2
    Peter Molenaar, Torsten Christ, Rizwan I Hussain, Andreas Engel, Emanuel Berk, Katherine T Gillette, Lu Chen, Alejandro Galindo-Tovar, Kurt A Krobert, Ursula Ravens, Finn Olav Levy, Alberto J Kaumann, PDE3, but not PDE4, reduces β1- and β2-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients, British Journal of Pharmacology, 2013, 169, 3
  3. 3
    Maqsood M. Elahi, Jimmy Lam, Sanjay Asopa, Bashir M. Matata, Levosimendan Versus an Intra-aortic Balloon Pump in Adult Cardiac Surgery Patients With Low Cardiac Output, Journal of Cardiothoracic and Vascular Anesthesia, 2011, 25, 6, 1154

    CrossRef

  4. 4
    Wayne C. Levy, Dariush Mozaffarian, David T. Linker, David J. Farrar, Leslie W. Miller, Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?, The Journal of Heart and Lung Transplantation, 2009, 28, 3, 231

    CrossRef

  5. 5
    Jennifer Barker, Charles Williams, Robert Tulloh, Understanding and treatment of heart failure, Paediatrics and Child Health, 2009, 19, 1, 1

    CrossRef

  6. 6
    Finn Olav Levy, Eirik Qvigstad, Kurt A. Krobert, Tor Skomedal, Jan-Bjørn Osnes, Effects of serotonin in failing cardiac ventricle: Signalling mechanisms and potential therapeutic implications, Neuropharmacology, 2008, 55, 6, 1066

    CrossRef

  7. 7
    Judith Hsia, Kathleen A. Jablonski, Madeline Murguia Rice, Marc S. Sabatine, Miguel Zabalgoitia, Aldo Maggioni, Thomas E. Cuddy, Michael J. Domanski, Nancy L. Geller, Greg Flaker, Scott Solomon, Torbjørn Omland, Jean L. Rouleau, Sudden Cardiac Death in Patients With Stable Coronary Artery Disease and Preserved Left Ventricular Systolic Function, The American Journal of Cardiology, 2008, 101, 4, 457

    CrossRef